Carregant...
Response to effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial.
Guardat en:
| Publicat a: | Int J Antimicrob Agents |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier Ltd and International Society of Antimicrobial Chemotherapy.
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7779261/ https://ncbi.nlm.nih.gov/pubmed/33408027 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijantimicag.2020.106237 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|